|
|
 |
QVAR REDIHALER Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
OSENI Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
RECARBRIO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
QTERN Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALPHA-TOCOPHEROL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
RAPIVAB Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|